Justin Low

1.1k total citations
30 papers, 522 citations indexed

About

Justin Low is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Justin Low has authored 30 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Justin Low's work include Glioma Diagnosis and Treatment (12 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and RNA and protein synthesis mechanisms (4 papers). Justin Low is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and RNA and protein synthesis mechanisms (4 papers). Justin Low collaborates with scholars based in United States, Australia and Netherlands. Justin Low's co-authors include Kevin M. Weeks, Quinn T. Ostrom, Jill S. Barnholtz‐Sloan, Kristin Waite, Corey Neff, Gino Cioffi, Carol Kruchko, Katherine B. Peters, Akanksha Sharma and Joseph Watts and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Justin Low

22 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Low United States 10 353 88 55 44 42 30 522
Apostolia Guialis Greece 17 579 1.6× 57 0.6× 90 1.6× 23 0.5× 59 1.4× 40 778
Devin Bready United States 7 276 0.8× 92 1.0× 28 0.5× 35 0.8× 121 2.9× 11 449
Kathleen Kaiser‐Rogers United States 12 425 1.2× 35 0.4× 18 0.3× 34 0.8× 52 1.2× 23 634
Ron Baik United States 9 497 1.4× 32 0.4× 21 0.4× 34 0.8× 55 1.3× 12 597
Juliane Menezes Portugal 13 294 0.8× 84 1.0× 40 0.7× 18 0.4× 45 1.1× 23 572
Supratik Das India 14 537 1.5× 22 0.3× 54 1.0× 81 1.8× 18 0.4× 35 794
Huiyan Jin United States 13 476 1.3× 30 0.3× 43 0.8× 45 1.0× 34 0.8× 21 610
Marion S. Schmidt-Zachmann Germany 14 599 1.7× 32 0.4× 42 0.8× 19 0.4× 36 0.9× 17 678
Wei Wen China 13 737 2.1× 24 0.3× 37 0.7× 42 1.0× 68 1.6× 18 803
Christopher R. Logg United States 19 630 1.8× 60 0.7× 82 1.5× 25 0.6× 45 1.1× 27 886

Countries citing papers authored by Justin Low

Since Specialization
Citations

This map shows the geographic impact of Justin Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Low more than expected).

Fields of papers citing papers by Justin Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Low. The network helps show where Justin Low may publish in the future.

Co-authorship network of co-authors of Justin Low

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Low. A scholar is included among the top collaborators of Justin Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Low. Justin Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, Mackenzie, Justin Low, Patrick R. Conlon, et al.. (2025). Improvements in survival for glioblastoma in the post-Stupp protocol era. Neuro-Oncology. 27(9). 2484–2486.
2.
Low, Justin, C. W. Chan, Chao‐Ling Yao, et al.. (2025). Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinoma. Molecular Medicine. 31(1). 247–247.
3.
Ali, Heba, Justin Low, David M. Ashley, et al.. (2025). Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors. Oncotarget. 16(1). 445–453. 1 indexed citations
4.
Johnson, Margaret, Kristen A. Batich, Justin Low, et al.. (2024). NIMG-77. MRI PHENOMENON OF PUNCTATE ENHANCING LESIONS IN PATIENTS TREATED WITH IDH INHIBITORS. Neuro-Oncology. 26(Supplement_8). viii213–viii213.
5.
Brown, Michael C., Justin Low, Michelle Bowie, & David M. Ashley. (2024). Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance. Journal of Clinical Investigation. 134(23). 1 indexed citations
6.
Low, Justin, Michael C. Brown, Zachary J. Reitman, et al.. (2024). Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma. Journal of Clinical Investigation. 134(2). 29 indexed citations
7.
Johnson, Margaret, Kristen A. Batich, Justin Low, et al.. (2024). INNV-31. THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii175–viii175.
8.
Johnson, Margaret, Kristen A. Batich, Justin Low, et al.. (2024). INNV-07. IVOSIDENIB AND BEVACIZUMAB IN HEAVILY PRETREATED PATIENTS WITH IDH1 MUTANT GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii170–viii170.
10.
Peters, Katherine B., Daniel Landi, Gloria Broadwater, et al.. (2023). Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma. Neuro-Oncology Practice. 11(2). 199–204. 11 indexed citations
11.
Tran, Peter, Justin Low, Manda Wong, et al.. (2022). Introducing Dendritic Cell Antibody Internalization as an Immunogenicity Risk Assessment Tool. Bioanalysis. 14(10). 703–713. 10 indexed citations
12.
Low, Justin, Quinn T. Ostrom, Gino Cioffi, et al.. (2022). Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians. Neuro-Oncology Practice. 9(3). 165–182. 71 indexed citations
13.
Sharma, Akanksha, Justin Low, & Priya Kumthekar. (2022). Advances in the Diagnosis and Treatment of Leptomeningeal Disease. Current Neurology and Neuroscience Reports. 22(7). 413–425. 9 indexed citations
14.
Desjardins, Annick, Vidyalakshmi Chandramohan, Daniel Landi, et al.. (2022). A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).. Journal of Clinical Oncology. 40(16_suppl). e14015–e14015. 9 indexed citations
15.
Khasraw, Mustafa, Justin Low, Kyle M. Walsh, et al.. (2022). Patterns of care in adult histone mutant gliomas: Results of an international survey. Neuro-Oncology Practice. 9(6). 520–525. 2 indexed citations
16.
Low, Justin, John P. Kirkpatrick, & Katherine B. Peters. (2021). Pineal Parenchymal Tumors of Intermediate Differentiation Treated With Ventricular Radiation and Temozolomide. Advances in Radiation Oncology. 7(1). 100814–100814. 5 indexed citations
17.
Low, Justin, Shih‐Hsiu J. Wang, & Katherine B. Peters. (2021). Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman. CNS Oncology. 10(2). CNS71–CNS71. 5 indexed citations
18.
Resnick, David, et al.. (2014). Seminal Plasma Hypersensitivity and Successful Intravaginal Graded Challenge. 10(1). 1 indexed citations
19.
Low, Justin & Kevin M. Weeks. (2010). SHAPE-directed RNA secondary structure prediction. Methods. 52(2). 150–158. 235 indexed citations
20.
Johnston, Christopher A., Екатерина С. Лобанова, Alexander S. Shavkunov, et al.. (2006). Minimal Determinants for Binding Activated Gα from the Structure of a Gαi1−Peptide Dimer,. Biochemistry. 45(38). 11390–11400. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026